Opus Capital Group, LLC Abb Vie Inc. Transaction History

Opus Capital Group, LLC

$800 Million
Q3 2024

A detailed history of Opus Capital Group, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Opus Capital Group, LLC holds 4,248 shares of ABBV stock, worth $777,723. This represents 0.1% of its overall portfolio holdings.

Number of Shares

4,248

Previous 4,265 0.4%

Holding current value

$777,723

Previous $732,000 14.62%

% of portfolio

0.1%

Previous 0.1%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 31, 2024	SELL	$163.84 - $199.33 $2,785 - $3,388	-17 Reduced 0.4%	4,248 $839,000
Q2 2024 Jul 31, 2024	BUY	$154.79 - $180.76 $24,302 - $28,379	157 Added 3.82%	4,265 $732,000
Q1 2024 Apr 26, 2024	SELL	$159.82 - $182.1 $85,823 - $97,787	-537 Reduced 11.56%	4,108 $748,000
Q4 2023 Jan 31, 2024	SELL	$137.6 - $154.97 $3,577 - $4,029	-26 Reduced 0.56%	4,645 $720,000
Q3 2023 Oct 31, 2023	SELL	$133.59 - $154.65 $58,245 - $67,427	-436 Reduced 8.54%	4,671 $696,000
Q2 2023 Jul 31, 2023	BUY	$132.51 - $164.9 $32,994 - $41,060	249 Added 5.13%	5,107 $688,000
Q1 2023 Apr 24, 2023	SELL	$144.61 - $166.54 $7,953 - $9,159	-55 Reduced 1.12%	4,858 $774,000
Q4 2022 Jan 18, 2023	BUY	$138.31 - $165.87 $4,979 - $5,971	36 Added 0.74%	4,913 $794,000
Q3 2022 Oct 31, 2022	SELL	$134.21 - $153.93 $4,026 - $4,617	-30 Reduced 0.61%	4,877 $655,000
Q2 2022 Jul 29, 2022	BUY	$137.62 - $174.96 $11,009 - $13,996	80 Added 1.66%	4,907 $752,000
Q1 2022 Apr 25, 2022	BUY	$131.98 - $163.75 $37,350 - $46,341	283 Added 6.23%	4,827 $783,000
Q4 2021 Jan 31, 2022	BUY	$107.43 - $135.93 $859 - $1,087	8 Added 0.18%	4,544 $615,000
Q3 2021 Oct 29, 2021	SELL	$106.4 - $120.78 $159,600 - $181,170	-1,500 Reduced 24.85%	4,536 $489,000
Q2 2021 Jul 29, 2021	SELL	$105.21 - $117.21 $55,024 - $61,300	-523 Reduced 7.97%	6,036 $680,000
Q1 2021 Apr 28, 2021	SELL	$102.3 - $112.62 $124,806 - $137,396	-1,220 Reduced 15.68%	6,559 $710,000
Q4 2020 Jan 29, 2021	BUY	$80.49 - $108.67 $59,482 - $80,307	739 Added 10.5%	7,779 $834,000
Q3 2020 Oct 30, 2020	BUY	$85.91 - $100.83 $14,948 - $17,544	174 Added 2.53%	7,040 $617,000
Q2 2020 Jul 31, 2020	BUY	$73.37 - $98.18 $137,642 - $184,185	1,876 Added 37.6%	6,866 $674,000
Q1 2020 Apr 30, 2020	BUY	$64.5 - $97.79 $321,855 - $487,972	4,990 New	4,990 $380,000
Q1 2019 Apr 30, 2019	SELL	$77.14 - $90.79 $571,144 - $672,209	-7,404 Closed	0 $0
Q4 2018 Feb 07, 2019	SELL	$77.85 - $96.01 $145,190 - $179,058	-1,865 Reduced 20.12%	7,404 $683,000
Q3 2018 Nov 06, 2018	SELL	$88.91 - $98.84 $83,130 - $92,415	-935 Reduced 9.16%	9,269 $877,000
Q1 2018 May 04, 2018	SELL	$92.01 - $123.21 $18,402 - $24,642	-200 Reduced 1.92%	10,204 $966,000
Q4 2017 Feb 02, 2018	BUY	$89.56 - $98.21 $123,324 - $135,235	1,377 Added 15.25%	10,404 $1.01 Million
Q3 2017 Nov 07, 2017	BUY	$69.85 - $89.22 $630,535 - $805,388	9,027	9,027 $802,000

Others Institutions Holding ABBV

# of Institutions

3,849

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $324B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Opus Capital Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Opus Capital Group, LLC with notifications on news.

Account

Opus Capital Group, LLC Abb Vie Inc. Transaction History